Copyright: ©Author(s) 2026.
World J Gastroenterol. Sep 14, 2026; 32(34): 119567
Published online Sep 14, 2026. doi: 10.3748/wjg.v32.i34.119567
Published online Sep 14, 2026. doi: 10.3748/wjg.v32.i34.119567
Table 2 Comparison of laboratory indicators of gastric cancer patients in the poor prognosis and good prognosis groups, mean ± SD
| Parameters | Good prognosis group (n = 143) | Poor prognosis group (n = 95) | t value | P value |
| Platelet count (× 109/L) | 207.46 ± 68.33 | 230.71 ± 74.25 | 2.482 | 0.014 |
| Neutrophil count (× 109/L) | 3.91 ± 1.12 | 4.32 ± 1.37 | 2.442 | 0.016 |
| Lymphocyte count (× 109/L) | 1.61 ± 0.38 | 1.48 ± 0.41 | 2.398 | 0.017 |
| Systemic immune-inflammation index | 503.83 ± 138.74 | 673.42 ± 152.91 | 8.864 | < 0.001 |
- Citation: Guo R, Gao M. Prognostic value of systemic immune-inflammation index in patients with gastric cancer treated with immune checkpoint inhibitors. World J Gastroenterol 2026; 32(34): 119567
- URL: https://www.wjgnet.com/1007-9327/full/v32/i34/119567.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i34.119567